Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease. [electronic resource]
Producer: 20070105Description: 1426-32 p. digitalISSN:- 1524-4571
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine -- administration & dosage
- Aged
- Brachial Artery -- physiology
- Coronary Artery Disease -- diagnostic imaging
- Cross-Over Studies
- Endothelium, Vascular -- drug effects
- Female
- Humans
- Intracellular Signaling Peptides and Proteins -- antagonists & inhibitors
- Lipids -- blood
- Male
- Middle Aged
- Nitroglycerin -- administration & dosage
- Protein Kinase Inhibitors -- administration & dosage
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Ultrasonography
- Vasodilation -- drug effects
- Vasodilator Agents -- administration & dosage
- rho-Associated Kinases
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.